Cardiopulmonary research

Research for healthy hearts and lungs

The heart and lungs interact in a complex interplay. Both systems are affected by partly similar risk factors and there is an overlap of pathogenic molecular mechanisms such as organ fibrosis. Due to high morbidity and mortality, diseases of the heart and lungs play a major role in terms of health economics.

A synergetic development

Fraunhofer ITEM researchers used magnetic resonance imaging to investigate the effects of the combination drug on patients’ heart function at the CRC Hannover.
© Fraunhofer ITEM

Establishment of a university-affiliated Division of Cardiovascular Research in 2021 has generated new methodological and scientific overlaps at Fraunhofer ITEM. As a result, the long-standing expertise in lung research is experiencing a synergetic further development of high clinical relevance. RNA molecules in particular are being investigated very successfully as diagnostic biomarkers and therapeutic targets for the benefit of patients with cardiac and pulmonary diseases. Computer-assisted translational bioinformatics, used to predict molecular mechanisms based on RNA molecules, is of particular importance in this context. Fraunhofer ITEM researchers are currently exploring the potential of RNAs for toxicology and efficacy testing of drugs. 

Advancing ideas to the proof of concept

© Fraunhofer ITEM
Through their clinical research, Fraunhofer ITEM scientists enable a direct transfer of findings to humans, for example, by using chip cytometry and exhaled breath analysis.

To efficiently translate ideas from bench to bedside, the scientists use appropriate exposure systems, some of which have been developed specifically for this purpose, and innovative model systems that closely mimic the situation in patients. They use the generated data to further develop and refine their modeling approaches, so as to allow in-vitro results or findings to be extrapolated both qualitatively and quantitatively for the prediction of the expected in-vivo effect in humans. Candidate drugs can be tested at the institute for their efficacy and side effects to provide the proof of concept in humans, i.e. the necessary evidence of the drug’s mode of action.

Cardiopulmonary research: recent projects and highlights


Investigation of neoepitope biomarkers

Fraunhofer ITEM scientists published novel data on neoepitope biomarkers of type I, III and VI collagen formation or degradation in precision-cut lung slices (PCLS) from patients with pulmonary fibrosis.


Project FibroPaths®

Therapeutic modulation of organ fibrosis in biochip format. 

Neutrophil subset as potential therapeutic target for secondary lung tissue injury

In collaboration with scientists from the Boston University School of Medicine, Fraunhofer ITEM researchers explored a new potential therapeutic target for neutrophil-mediated secondary tissue injury.

Non-invasive examination of the lungs by means of exhaled particles

Inhaled booster Vaccination against Corona

In cooperation with the Hannover Medical School, Fraunhofer ITEM scientists are investigating the safety and efficacy of inhaled booster vaccination in a phase-I trial. 


Threshold dose on ambrosia pollen

With a newly developed experimental setup in the Fraunhofer Allergen Challenge Chamber (Fraunhofer ACC), the Fraunhofer scientists can messure allergenic potency of ambrosia pollen. 

Development of RNA therapeutics

Innovative RNA therapeutics are being developed in the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD. 

Alternatives to animal models

A new position paper by the European Society of Cardiology presents advances in medicine through human-relevant disease models (main author: Prof. Thomas Thum). 

Checking the immune response in the lungs

Using chip cytometry, Fraunhofer ITEM researchers have established a procedure for characterizing immune cells in the lungs. With this technique, valuable samples from patients can be stored for months.


Lung pharmacokinetics

Clinical evaluation of the lung pharmacokinetics of inhaled and systemic drugs.


Precision-cut lung slices

Precision-cut lung slices allow early events in the pathogenesis of respiratory diseases to be studied in human lung tissue.

Project archive

Here you can find more projects sorted by our research and development competences. 

You may also be interested in these topics:

Coronavirus research at Fraunhofer ITEM

As an institute with decades of experience in infection and airway research Fraunhofer ITEM can make an important contribution to scientific progress in the fight against the coronavirus SARS-CoV-2.

Clinical studies at Fraunhofer ITEM

We are a highly specialized, academia-affiliated research center for early-phase and proof-of-concept clinical trials.

#WeKnow ClinicalResearch

Get some insights into our clinical airway research in our video series #WeKnowClinicalResearch.


  • Arbustini, E., Behr, E. R., Carrier, L., van Duijn, C., Evans, P., Favalli, V., van der Harst, P., Haugaa, K. H., Jondeau, G., Kaab, S., Kaski, J. P., Kavousi, M., Loeys, B., Pantazis, A., Pinto, Y., Schunkert, H., Di Toro, A., Thum, T., Urtis, M., Waltenberger, J., Elliott, P. (2022). Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics. European Heart Journal [Epub ahead of print]: 17 p. doi: 10.1093/eurheartj/ehab895  - Open Access
  • Badi, Y. E., Pavel, A. B., Pavlidis, S., Riley, J. H., Bates, S., Kermani, N. Z., Knowles, R., Kolmert, J., Wheelock, C. E., Worsley, S., Uddin, M., Alving, K., Bakke, P. S., Behndig, A., Caruso, M., Chanez, P., Fleming, L. J., Fowler, S. J., Frey, U., Howarth, P., Horvath, I., Krug, N., Maitland-van der Zee, A. H., Montuschi, P., Roberts, G., Sanak, M., Shaw, D. E., Singer, F., Sterk, P. J., Djukanovic, R., Dahlen, S. E., Guo, Y. K., Chung, K. F., Guttman-Yassky, E., Adcock, I. M., Group, U. B. S. (2022). Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma. Journal of Allergy and Clinical Immunology 149(1): 89-101. doi: 10.1016/j.jaci.2021.04.010
  • Bei, Y., Lu, D., Bar, C., Chatterjee, S., Costa, A., Riedel, I., Mooren, F. C., Zhu, Y., Huang, Z., Wei, M., Hu, M., Liu, S., Yu, P., Wang, K., Thum, T., Xiao, J. (2022). miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection. Molecular Therapy 30(4): 1675-1691. doi: 10.1016/j.ymthe.2022.01.031 -
  • Biener, M., Giannitsis, E., Thum, T., Bar, C., Stoyanov, K. M., Salbach, C., de Gonzalo-Calvo, D., Frey, N., Mueller-Hennessen, M. (2022). Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department. Clinical Biochemistry 99: 9-16. doi: 10.1016/j.clinbiochem.2021.09.009
  • Carstensen, S., Benediktus, E., Litzenburger, T., Hohlfeld, J. M., Muller, M. (2022). Basophil activation test: Assay precision and BI 1002494 SYK inhibition in healthy and mild asthmatics. Cytometry A 101(1): 86-94. doi: 10.1002/cyto.a.24338  - Open Access
  • Costa, A., Cushman, S., Haubner, B. J., Derda, A. A., Thum, T., Bar, C. (2022). Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration. Basic Research in Cardiology 117(1): 26. doi: 10.1007/s00395-022-00931-w - Open Access
  • Davidson, S. M., Boulanger, C. M., Aikawa, E., Badimon, L., Barile, L., Binder, C. J., Brisson, A., Buzas, E., Emanueli, C., Jansen, F., Katsur, M., Lacroix, R., Lim, S. K., Mackman, N., Mayr, M., Menasche, P., Nieuwland, R., Sahoo, S., Takov, K., Thum, T., Vader, P., Wauben, M. H. M., Witwer, K., Sluijter, J. P. G. (2022). Methods for the identification and characterization of extracellular vesicles in cardiovascular studies - from exosomes to microvesicles. Cardiovascular Research [Epub ahead of print]. doi: 10.1093/cvr/cvac031
  • de Boer, R. A., Heymans, S., Backs, J., Carrier, L., Coats, A. J. S., Dimmeler, S., Eschenhagen, T., Filippatos, G., Gepstein, L., Hulot, J. S., Knoll, R., Kupatt, C., Linke, W. A., Seidman, C. E., Tocchetti, C. G., van der Velden, J., Walsh, R., Seferovic, P. M., Thum, T. (2022). Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC). European Journal of Heart Failure 24(3): 406-420. doi: 10.1002/ejhf.2414 - Open Access
  • De Sadeleer, L. J., Verleden, S. E., Schupp, J. C., McDonough, J. E., Goos, T., Yserbyt, J., Bargagli, E., Rottoli, P., Kaminski, N., Prasse, A., Wuyts, W. A. (2022). BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact. Chest [Epub ahead of print]. doi: 10.1016/j.chest.2021.12.668
  • Gonzalez, A., Richards, A. M., de Boer, R. A., Thum, T., Arfsten, H., Hulsmann, M., Falcao-Pires, I., Diez, J., Foo, R. S. Y., Chan, M. Y., Aimo, A., Anene-Nzelu, C. G., Abdelhamid, M., Adamopoulos, S., Anker, S. D., Belenkov, Y., Gal, T. B., Cohen-Solal, A., Bohm, M., Chioncel, O., Delgado, V., Emdin, M., Jankowska, E. A., Gustafsson, F., Hill, L., Jaarsma, T., Januzzi, J. L., Jhund, P. S., Lopatin, Y., Lund, L. H., Metra, M., Milicic, D., Moura, B., Mueller, C., Mullens, W., Nunez, J., Piepoli, M. F., Rakisheva, A., Ristic, A. D., Rossignol, P., Savarese, G., Tocchetti, C. G., Van Linthout, S., Volterrani, M., Seferovic, P., Rosano, G., Coats, A. J. S., Bayes-Genis, A. (2022). Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure [Epub ahead of print]. doi: 10.1002/ejhf.2493  - Open Access
  • Heratizadeh, A., Roesner, L. M., Traidl, S., Moitinho-Silva, L., Ellinghusen, B., Rodriguez, E., Harder, I., Sapak, M., Weidinger, S., Badorrek, P., Hohlfeld, J. M., Werfel, T. (2022). Basic skin therapy effects on skin inflammation and microbiome composition in patients with atopic dermatitis after challenges with grass pollen. Journal of the European Academy of Dermatology and Venereology [Epub ahead of print]. doi: 10.1111/jdv.17966
  • Herrera, V. L. M., Walkey, A. J., Nguyen, M. Q., Gromisch, C. M., Mosaddhegi, J. Z., Gromisch, M. S., Jundi, B., Lukassen, S., Carstensen, S., Denis, R., Belkina, A. C., Baron, R. M., Pinilla-Vera, M., Mueller, M., Kimberly, W. T., Goldstein, J. N., Lehmann, I., Shih, A. R., Eils, R., Levy, B. D., Ruiz-Opazo, N. (2022). A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS. Scientific Reports 12(1): 5583. doi: 10.1038/s41598-022-09343-1  - Open Access
  • Hoda, U., Pavlidis, S., Bansal, A. T., Takahashi, K., Hu, S., Ng Kee Kwong, F., Rossios, C., Sun, K., Bhavsar, P., Loza, M., Baribaud, F., Chanez, P., Fowler, S. J., Horvath, I., Montuschi, P., Singer, F., Musial, J., Dahlen, B., Krug, N., Sandstrom, T., Shaw, D. E., Lutter, R., Fleming, L. J., Howarth, P. H., Caruso, M., Sousa, A. R., Corfield, J., Auffray, C., De Meulder, B., Lefaudeux, D., Dahlen, S. E., Djukanovic, R., Sterk, P. J., Guo, Y., Adcock, I. M., Chung, K. F., group, U. B. s. (2022). Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort. Clin Transl Med 12(4): e816. doi: 10.1002/ctm2.816  - Open Access
  • Holz, O., Muller, M., Carstensen, S., Olin, A. C., Hohlfeld, J. M. (2022). Inflammatory cytokines can be monitored in exhaled breath particles following segmental and inhalation endotoxin challenge in healthy volunteers. Scientific Reports 12(1): 5620. doi: 10.1038/s41598-022-09399-z - Open Access
  • Holz, O., van Vorstenbosch, R., Guenther, F., Schuchardt, S., Trinkmann, F., van Schooten, F. J., Smolinska, A., Hohlfeld, J. M. (2022). Changes of breath volatile organic compounds in healthy volunteers following segmental and inhalation endotoxin challenge. Journal of Breath Research 16(3). doi: 10.1088/1752-7163/ac6359  - Open Access
  • Kreutzer, F. P., Meinecke, A., Mitzka, S., Hunkler, H. J., Hobuss, L., Abbas, N., Geffers, R., Weusthoff, J., Xiao, K., Jonigk, D. D., Fiedler, J., Thum, T. (2022). Development and characterization of anti-fibrotic natural compound similars with improved effectivity. Basic Research in Cardiology 117(1): 9. doi: 10.1007/s00395-022-00919-6  - Open Access
  • Kreutzer, F. P., Meinecke, A., Schmidt, K., Fiedler, J., Thum, T. (2022). Alternative strategies in cardiac preclinical research and new clinical trial formats. Cardiovascular Research 118(3): 746-762. doi: 10.1093/cvr/cvab075  - Open Access
  • Leonardy, J., Bar, C. (2022). Editorial Research Topic: Non-coding RNA as Therapeutic Target: A Game Changer in Cardiac Regenerative Strategies? Frontiers in Physiology 12: 822280. doi: 10.3389/fphys.2021.822280  - Open Access
  • Lu, D., Chatterjee, S., Xiao, K., Riedel, S., Huang, C., Costa, A., Cushman, S., Neufeldt, D., Rode, L., Schmidt, A., Juchem, M., Leonardy, J., Büchler, G., Blume, J., Gern, O., Kalinke, U., Tan, W., Foo, R., Vink, A., van Laake L., van der Meer, P., Bär, C., Thum, T. (2022). A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity. European Heart Journal. doi: 10.1093/ehac337
  • Makarewich, C. A., Thum, T. (2022). Exercise-Induced Long Noncoding RNAs As New Players in Cardiac Hypertrophy. Circulation 145(16): 1234-1237. doi: 10.1161/CIRCULATIONAHA.122.059278
  • Mullens, W., Martens, P., Testani, J. M., Tang, W. H. W., Skouri, H., Verbrugge, F. H., Fudim, M., Iacoviello, M., Franke, J., Flammer, A. J., Palazzuoli, A., Barragan, P. M., Thum, T., Marcos, M. C., Miro, O., Rossignol, P., Metra, M., Lassus, J., Orso, F., Jankowska, E. A., Chioncel, O., Milicic, D., Hill, L., Seferovic, P., Rosano, G., Coats, A., Damman, K. (2022). Renal effects of guideline directed medical therapies in heart failure - a consensus document from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure [Epub ahead of print]. doi: 10.1002/ejhf.2471 - Open Access
  • Obernolte, H., Niehof, M., Braubach, P., Fieguth, H. G., Jonigk, D., Pfennig, O., Tschernig, T., Warnecke, G., Braun, A., Sewald, K. (2022). Cigarette smoke alters inflammatory genes and the extracellular matrix - investigations on viable sections of peripheral human lungs. Cell and Tissue Research 387(2): 249-260. doi: 10.1007/s00441-021-03553-1  - Open Access
  • Obert, A. J., Gutberlet, M., Kern, A. L., Kaireit, T. F., Glandorf, J., Moher Alsady, T., Wacker, F., Hohlfeld, J. M., Vogel-Claussen, J. (2022). Examining lung microstructure using (19) F MR diffusion imaging in COPD patients. Magnetic Resonance in Medicine [Epub ahead of print]. doi: 10.1002/mrm.29237  - Open Access
  • Preuss, E. B., Schubert, S., Werlein, C., Stark, H., Braubach, P., Hofer, A., Plucinski, E. K. J., Shah, H. R., Geffers, R., Sewald, K., Braun, A., Jonigk, D. D., Kuhnel, M. P. (2022). The challenge of long-term cultivation of human precision-cut lung slices. American Journal of Pathology 192(2): 239-253. doi: 10.1016/j.ajpath.2021.10.020  - Open Access
  • Sparreman Mikus, M., Kolmert, J., Andersson, L. I., Ostling, J., Knowles, R. G., Gomez, C., Ericsson, M., Thorngren, J. O., Emami Khoonsari, P., Dahlen, B., Kupczyk, M., De Meulder, B., Auffray, C., Bakke, P. S., Beghe, B., Bel, E. H., Caruso, M., Chanez, P., Chawes, B., Fowler, S. J., Gaga, M., Geiser, T., Gjomarkaj, M., Horvath, I., Howarth, P. H., Johnston, S. L., Joos, G., Krug, N., Montuschi, P., Musial, J., Nizankowska-Mogilnicka, E., Olsson, H. K., Papi, A., Rabe, K. F., Sandstrom, T., Shaw, D. E., Siafakas, N. M., Uhlen, M., Riley, J. H., Bates, S., Middelveld, R. J. M., Wheelock, C. E., Chung, K. F., Adcock, I. M., Sterk, P. J., Djukanovic, R., Nilsson, P., Dahlen, S. E., James, A., Group, U. B. S., the, B. C. (2022). Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation. European Respiratory Journal 59(2). doi: 10.1183/13993003.00142-2021  -
  • Thum, T. (2022). Orchestration of vascular smooth muscle cell plasticity using epigenetic therapy. European Heart Journal [Epub ahead of print]. doi: 10.1093/eurheartj/ehac200  - Open Access
  • van der Velden, J., Asselbergs, F. W., Bakkers, J., Batkai, S., Bertrand, L., Bezzina, C. R., Bot, I., Brundel, B., Carrier, L., Chamuleau, S., Ciccarelli, M., Dawson, D., Davidson, S. M., Dendorfer, A., Duncker, D. J., Eschenhagen, T., Fabritz, L., Falcao-Pires, I., Ferdinandy, P., Giacca, M., Girao, H., Gollmann-Tepekoylu, C., Gyongyosi, M., Guzik, T. J., Hamdani, N., Heymans, S., Hilfiker, A., Hilfiker-Kleiner, D., Hoekstra, A. G., Hulot, J. S., Kuster, D. W. D., van Laake, L. W., Lecour, S., Leiner, T., Linke, W. A., Lumens, J., Lutgens, E., Madonna, R., Maegdefessel, L., Mayr, M., van der Meer, P., Passier, R., Perbellini, F., Perrino, C., Pesce, M., Priori, S., Remme, C. A., Rosenhahn, B., Schotten, U., Schulz, R., Sipido, K., Sluijter, J. P. G., van Steenbeek, F., Steffens, S., Terracciano, C. M., Tocchetti, C. G., Vlasman, P., Yeung, K. K., Zacchigna, S., Zwaagman, D., Thum, T. (2022). Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research [Epub ahead of print]. doi: 10.1093/cvr/cvab370  -
  • Voskrebenzev, A., Kaireit, T. F., Klimeš, F., Pöhler, G. H., Behrendt, L., Biller, H., Berschneider, K., Wacker, F., Welte, T., Hohlfeld, J. M., Vogel-Claussen, J. (2022). PREFUL MRI Depicts Dual Bronchodilator Changes in COPD: A Retrospective Analysis of a Randomized Controlled Trial. Radiology: Cardiothoracic Imaging 4(2). doi: 10.1148/ryct.210147  - Open Access